Rapid CTA 360

by RapidAI  · Based in United States → — Clinical AI Platform Enhancing Assessment & Care
Emergency Medicine Neurology Radiology

Regulatory Status Disclosed

Overview

Rapid CTA 360, developed by RapidAI (formerly iSchemaView), is an advanced AI-powered imaging solution designed to revolutionize stroke diagnosis and treatment planning. It provides fully automated, high-quality 3D reconstructions of head, neck, and aortic arch CT angiography (CTA) scans within minutes. The tool enhances visibility of distal occlusions and collateral flow through color-coded overlays that identify brain regions with reduced blood vessel density. Physicians can view and analyze these 3D reconstructions from multiple angles, facilitating precise stroke diagnosis and treatment decisions. Rapid CTA 360 is part of the broader RapidAI platform, which offers a comprehensive suite of AI tools for acute stroke care, aiming to expedite time to treatment, improve workflow efficiencies, and ultimately enhance patient outcomes.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Automated 3D CTA reconstructions of head, neck, and aortic arch
  • Color-coded overlays for identifying brain regions with reduced blood vessel density
  • Multi-angle 3D reconstructions for precise visualization of vasculature
  • Automated assessment of collateral vessels
  • Mobile device access for remote viewing and analysis
  • Integration with PACS and reporting systems
  • AI-driven worklist prioritization (as part of RapidAI platform)
  • Reduced manual steps and cognitive burden for radiologists
  • Facilitates clinical decision-making and patient triage
  • Supports collaboration between community hospitals and specialists

Use Cases

  • Acute ischemic stroke diagnosis and treatment planning
  • Identification of large vessel occlusions (LVO)
  • Patient selection for mechanical thrombectomy
  • Expediting time between CT and CTA scans
  • Remote image review and consultation
  • Workflow triage and prioritization of medical images

What Physicians Need to Know

Stroke Detection Speed
Rapid CTA can quickly detect anterior circulation Large Vessel Occlusions (LVOs) with a mean average time of 3 minutes 30 seconds. It can also expedite time between CT and CTA scans with prompt LVO notifications, and has been shown to reduce time to treatment for Rapid CTA by 25 minutes.
Brain MRI/CT Analysis
Rapid CTA automatically processes CT scans to provide clear CT angiography images, including color-coded overlays to identify brain regions with reduced blood vessel density. It also offers 3D reconstructions of the vasculature, allowing physicians to rotate images for optimal viewing from multiple angles. The RapidAI platform includes a comprehensive suite of tools for ischemic stroke, spanning NCCT, CTA, CTP, and intervention.
Large Vessel Occlusion Detection
Rapid CTA is designed for fast and reliable detection of LVOs in intracranial ICA and M1 MCA. It has demonstrated a sensitivity of 96% and specificity of 98% for anterior circulation LVOs. In a study, Rapid CTA showed an 80% sensitivity and 95% positive predictive value for LVO detection using a 45% relative vessel density threshold. Rapid CTA uses AI to enhance visibility of distal occlusions and collateral flow with vessel density asymmetry.
Triage Prioritization Speed
RapidAI's NCCT Stroke solution can expedite time between CT and CTA scans with prompt LVO notifications and enable stroke detection at any center for equitable care. It has been shown to improve time to triage decision by emergency physicians by 18 minutes. Rapid ICH, another RapidAI module, uses AI to speed up the triage of NCCT and notify clinicians of suspected ICH cases within three minutes.
ASPECTS Score Automation
Rapid ASPECTS provides an automated system for scoring non-contrast CT scans in the presence of LVOs based on the Alberta Stroke Program Early CT Score (ASPECTS) system. This automation helps determine thrombectomy eligibility, quickly visualize regions of asymmetry, and review measurements of ischemic change. It can deliver a standardized ASPECT score in less than 2 minutes and has been shown to improve clinician diagnostic accuracy and increase reader reliability.
Mobile Notification System
RapidAI offers mobile and web applications that integrate seamlessly with its modules. The system includes remote viewing functionality, allowing image maps to be displayed for review on any desktop, notebook computer, or other mobile device. This remote viewing facilitates clinical decision-making, patient triage, and collaboration. The Brainomix 360 Mobile app (a similar AI-powered stroke imaging platform) provides quick, secure access to AI-powered scan results, allows flagging for thrombectomy with a single swipe, and enables secure messaging and calling for care coordination.
Physician Tip

Rapid CTA can significantly enhance the speed and accuracy of stroke diagnosis, particularly for large vessel occlusions. Leverage the automated ASPECTS scoring to standardize assessments and improve inter-reader agreement, especially in settings without immediate neuroradiologist availability. Utilize the mobile notification system for rapid access to critical imaging results and to streamline communication within the stroke care team, facilitating quicker treatment decisions and patient transfers. The 3D reconstructions and color-coded overlays can provide a more comprehensive understanding of the vasculature and collateral flow, aiding in treatment planning. Remember that AI tools like Rapid CTA are intended to complement, not replace, clinical interpretation.

The Rapid Enterprise™ Platform is designed for seamless integration with existing IT infrastructure, including PACS, RIS, worklist providers, EHR systems, and communication platforms. It supports standard (HL7, FHIR, DICOM) and custom APIs. The platform also allows for the integration of trusted third-party algorithms, providing a comprehensive solution across various service lines. This ensures that AI findings are surfaced directly within familiar workflows, reducing cognitive burden and improving care coordination.

Details

Category Neurology AI, Radiology & Imaging AI
Pricing Unknown
DeploymentEnterprise infrastructure, integrates into existing stack
TrainingUnknown
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurology, Radiology

Support & Reliability

Training ProvidedUnknown

What the Web Says

Rapid CTA 360, part of the RapidAI platform, is an AI-powered software designed to assist clinicians in the rapid assessment of stroke patients by analyzing CT images. It aims to improve acute stroke care by creating efficiencies in the diagnostic process, particularly for detecting large vessel occlusions (LVOs) and intracranial hemorrhage (ICH). The platform provides automated analysis of CT angiography (CTA) and CT perfusion (CTP) scans, delivering results quickly to aid in clinical decision-making, patient triage, and transfers to specialized centers. While it has shown potential in improving turnaround times for radiology reports, some sources highlight the need for more robust studies to fully understand its impact on patient outcomes and cost-effectiveness.

Overall: Mixed

Strengths

  • Potential to improve acute stroke care by increasing diagnostic process efficiencies.
  • Aids in rapid detection of large vessel occlusions (LVOs) and intracranial hemorrhage (ICH).
  • Provides clear, easy-to-interpret CTA maps with color-coded scales and 3D reconstructions.
  • Offers remote viewing capabilities for physicians on various devices.
  • Can reduce radiology-report turnaround time.
  • Neuro stroke teams generally appreciate the data provided by RapidAI.

Limitations

  • Impact on many patient-important outcomes (e.g., harms, mortality, quality of life, hospital stay) is uncertain due to limited evidence.
  • Cost-effectiveness of RapidAI for stroke detection is currently unknown.
  • Estimates of sensitivity and specificity for detecting LVO varied across studies using different modules.
  • Ethical considerations regarding data privacy, equitable access, and algorithmic bias need to be addressed.
  • AI can sometimes misread scans, especially with patient movement, requiring radiologist review.
  • Some radiologists on Reddit have noted instances of AI incorrectly identifying or missing conditions.

Based on reviews from: NCBI Bookshelf, Indeed.com, ResearchGate, Elion Health, SourceForge, NeuroNews International, Canada's Drug Agency, Xtalks, Reddit, PubMed, Healthcare Industry Reviews

Last updated: 2026-10-26

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Rapid CTA 360

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

accessdata.fda.gov
510(k) Premarket Notification K251151 - Rapid CTA 360
The FDA granted 510(k) clearance to iSchemaView for Rapid CTA 360 on July 16, 2025. This radiological computer-aided triage and notification software uses AI/ML to analyze adult head CTA images for suspected large and medium vessel neuro-occlusions.
2025-07
Innolitics
2025 Year in Review: Cardiology AI/ML SaMD 510(k) Clearances
This article provides a comprehensive analysis of 2025 cardiology AI/ML clearances, including the Rapid CTA 360 by iSchemaView, which received its 510(k) clearance on July 16, 2025.
2026-01
X-ray Interpreter
Rapid CTA 360 | FDA Radiology AI Device
Rapid CTA 360, developed by iSchemaView Inc., is listed as a 2025 510K FDA-cleared device. It is designed to detect large-vessel occlusion, perfusion deficits, and aortic findings.
2025-08
Osler, Hoskin & Harcourt LLP
Governing AI in Ontario hospitals: oversight, opportunity and risk
This article discusses the governance of AI in Ontario hospitals, mentioning Rapid CTA 360 (K251151) as a device that detects large-vessel occlusion, perfusion deficits, and aortic findings.
2026-07
Rad AI Slice
AI Models Diagnose Dementia Across Real-World Brain Images | Rad AI Slice
Rapid CTA 360 (K251151) is noted for triaging and notifying critical findings on CT angiography for urgent vascular care.
2025-07
Innolitics
Definitive Guide to AI/ML SaMD Ground Truthing
This guide on AI/ML SaMD ground truthing references Rapid CTA 360 (K251151) and its final performance validation, which included 403 CTA cases with ground truth established by three experts.
2025-09
Innolitics
Foundation Models in AI SaMD: A Snapshot
This article discusses how regulatory documentation for devices like Rapid CTA 360 often uses generic machine learning terms to describe their technology, despite marketing materials highlighting foundation models.
2026-05

Videos

Product demos, reviews, and walkthroughs for Rapid CTA 360.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

Rapid CTA 360, encompassing modules like Rapid CTA and Lumina 3D by RapidAI, primarily addresses acute stroke care by facilitating the rapid detection of large vessel occlusions (LVOs) and intracranial hemorrhages (ICH) through automated CT angiography analysis and 3D reconstructions. It integrates into existing workflows by providing fast, automated image processing and delivering results to clinicians via PACS, email, and mobile devices, enabling quicker diagnostic and treatment decisions.
Rapid CTA 360 significantly enhances speed and efficiency by providing automated analysis and 3D reconstructions of CTA scans within minutes, which traditionally take hours with manual methods. This rapid processing, coupled with real-time alerts and mobile access to critical imaging, helps expedite triage, treatment, and transfer decisions for stroke patients.
Rapid CTA, a core component of Rapid CTA 360, has received FDA 510(k) clearance as a Class II medical device. While it is a cleared tool to aid in clinical decision-making, it is intended to complement, rather than replace, direct clinician interpretation of CT imaging.
Key alternatives in AI-powered neurovascular imaging analysis include platforms like Aidoc, Viz.ai, and Brainomix 360 Stroke. RapidAI differentiates itself through its comprehensive enterprise platform offering a broad suite of clinically validated modules for various stroke and vascular conditions, along with advanced 3D reconstruction capabilities and seamless workflow integration.
It is crucial to understand that Rapid CTA 360 is a decision support tool and should not be used in isolation, as it complements rather than replaces clinician interpretation. Potential pitfalls include the possibility of false positives due to imaging artifacts or software limitations, and some studies indicate a need for more evidence on its direct impact on patient-important outcomes.
Rapid CTA 360 is typically offered under an annual subscription model, with pricing varying based on factors like region, hospital type, and the specific modules purchased. The cost-benefit analysis often highlights a strong return on investment through reduced post-processing times, increased treatment revenue by identifying more eligible patients, and cost savings from avoiding unnecessary patient transfers.

Related Tools

Parkiwatch
Koios Care
Neurology AI
Parkiwatch by Koios Care is a Class IIa Software as a Medical Device (EU MDR 2017/745) for continuous, passive detection and quantitative assessment of kinematic patterns representative of tremor, bradykinesia, and dyskinesia in adults with Parkinson's Disease.
CortiCare (Virtual EEG Department)
CortiCare
Neurology AI
CortiCare offers 24/7 remote EEG monitoring and interpretation services, functioning as a virtual EEG department to assist hospitals and neurology practices in identifying seizures and other neurological conditions.
NeuroAstra
Avinya NeuroTech
Clinical Decision Support & Reference
NeuroAstra is an AI-enabled EEG analysis and reporting software that provides a multimodal clinical EEG web platform with Co-Pilot AI to help neuro care teams detect abnormal trends faster and standardize reporting.
Cercare Medical Oncology Virtual Expert
Cercare Medical
Neurology AI
Cercare Medical's Oncology Virtual Expert is an AI-powered brain tumor segmentation module that provides fast, consistent, and semi-automated tumor analysis from standard MRI data, designed for on-premise deployment within existing clinical radiology workflows.
CoLumbo C-Spine
Smart Soft Healthcare AD
Clinical Decision Support & Reference
CoLumbo C-Spine is an AI-powered software that processes and analyzes cervical spine MRI exams, assisting clinicians in diagnosis and assessment.
MeRT System
Wave Neuroscience
Mental & Behavioral Health AI
MeRT (Magnetic e-Resonance Therapy) is an advanced, personalized form of TMS that uses your own brainwave data to guide treatment. It's a non-invasive, drug-free option designed to help the brain communicate more efficiently so symptoms of conditions like depression, anxiety, PTSD, TBI, autism, and more can improve.

See all Neurology AI tools →

More from RapidAI (formerly iSchemaView)

iSchemaView RAPID
RapidAI (formerly iSchemaView)
Neurology AI
RapidAI is an AI-enabled software platform that facilitates the viewing, processing, and analysis of CT and MRI imaging to aid clinicians in assessing patients with suspected stroke, providing automated results for faster, more accurate diagnostic and treatment decisions.
Rapid
RapidAI
Neurology AI
RapidAI is an AI-driven medical imaging analysis and coordinated care platform that empowers healthcare teams to rapidly, precisely, and confidently manage life-threatening conditions, especially acute stroke, through advanced CT and MRI image processing.
Rapid LVO
RapidAI (formerly iSchemaView)
Neurology AI
Rapid LVO by RapidAI is an FDA-cleared AI tool for the fast and accurate detection of Large Vessel Occlusions (LVOs) in acute stroke patients using CTA imaging, streamlining triage and care coordination.
Rapid PE Triage and Notification (PETN)
RapidAI (formerly iSchemaView)
Cardiology AI
Rapid PE Triage and Notification (PETN) by RapidAI is an AI-powered software that analyzes CTPA images to rapidly identify and notify clinicians of suspected central pulmonary embolisms, streamlining workflow and accelerating patient care pathways.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-21 | First Added: 2026-04-21
AI Tool Finder
AI-powered search. Results may not be comprehensive.